Astrana Health (NASDAQ:ASTH) Sets New 12-Month High – Still a Buy?
by Michael Walen · The Markets DailyAstrana Health, Inc. (NASDAQ:ASTH – Get Free Report)’s stock price hit a new 52-week high on Monday . The company traded as high as $40.58 and last traded at $39.6450, with a volume of 67712 shares traded. The stock had previously closed at $39.17.
Analyst Upgrades and Downgrades
Several research firms recently commented on ASTH. Robert W. Baird set a $45.00 target price on Astrana Health in a research report on Friday, May 8th. Truist Financial lifted their price objective on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. BTIG Research reissued a “buy” rating and issued a $50.00 price target on shares of Astrana Health in a report on Tuesday, June 2nd. Weiss Ratings raised Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. Finally, TD Cowen upped their target price on Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Astrana Health has an average rating of “Moderate Buy” and an average price target of $45.00.
Read Our Latest Research Report on Astrana Health
Astrana Health Trading Up 1.6%
The firm has a market capitalization of $2.22 billion, a PE ratio of 65.25 and a beta of 1.00. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.20. The stock’s fifty day simple moving average is $36.10 and its 200 day simple moving average is $28.10.
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.45. The company had revenue of $965.10 million during the quarter, compared to the consensus estimate of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. Astrana Health’s quarterly revenue was up 55.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.42 EPS. On average, sell-side analysts predict that Astrana Health, Inc. will post 1.25 earnings per share for the current year.
Institutional Trading of Astrana Health
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Quantbot Technologies LP boosted its stake in shares of Astrana Health by 384.4% in the third quarter. Quantbot Technologies LP now owns 40,659 shares of the company’s stock valued at $1,153,000 after purchasing an additional 32,265 shares during the period. Insight Wealth Strategies LLC acquired a new stake in Astrana Health during the fourth quarter valued at approximately $3,514,000. 325 Capital LLC lifted its stake in Astrana Health by 34.6% during the third quarter. 325 Capital LLC now owns 1,193,953 shares of the company’s stock worth $33,849,000 after purchasing an additional 307,037 shares during the last quarter. Hussman Strategic Advisors Inc. boosted its holdings in shares of Astrana Health by 200.0% in the 4th quarter. Hussman Strategic Advisors Inc. now owns 63,000 shares of the company’s stock valued at $1,563,000 after buying an additional 42,000 shares during the period. Finally, UBS Group AG grew its holdings in shares of Astrana Health by 48.4% during the fourth quarter. UBS Group AG now owns 176,100 shares of the company’s stock valued at $4,369,000 after purchasing an additional 57,432 shares during the last quarter. 52.77% of the stock is owned by institutional investors and hedge funds.
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.